Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the ...

Remedy Pharmaceuticals, a leader in stroke drug development today announced efficacy data from the Phase 2 GAMES-RP and Phase 3 CHARM studies of CIRARA (intravenous glyburide) for the treatment of ...

University of Cincinnati experts will present research at the International Stroke Conference 2025 in Los Angeles.

Fewer women received cardiology referrals during index hospitalization and poststroke cardiac monitoring compared with men, ...

This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix's AI-powered software to expand access to life-changing stroke treatments across ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

South Korea showcases top 10 innovative medical devices at annual report meeting South Korea reveals its top ten groundbreaking healthcare technologies at a major annual event ...

Central University Hospital announced on the 10th that it has introduced a state-of-the-art linear accelerator that can ...

The secondary focus was to see if the effect of in-person, hands-on (escape room) nurse education would improve individualized stroke-patient education compliance compared to eLearning and poster ...

Introduction: Ongoing staff stroke education is crucial to ensure that stroke knowledge remains current and at the forefront of everyone's minds and is also required for stroke certification. The ...